Healthcare services: approx. 70%
Pharmacies: approx. 20%
Health insurance and other services: approx. 10%

India: approx. 85%
Middle East: approx. 10%
Southeast Asia: approx. 5%

Apollo Hospitals Enterprise Limited generates the majority of its revenue from healthcare services, including hospital operations and medical care. The company's pharmacy chain also contributes significantly to the revenue, while health insurance and other services make up a smaller share.

The Indian market is the dominant revenue driver, attributed to the strong presence and extensive network of hospitals and pharmacies in the country. The Middle East and Southeast Asia are important international markets served through strategic partnerships and expansions.

Production Sites: India

Apollo Hospitals Enterprise Limited is a leading healthcare company in India and operates a network of hospitals, pharmacies, and diagnostic centers throughout the country. The company does not produce physical products in the traditional sense, but offers medical services.

The services and medical offerings of Apollo Hospitals are provided in their facilities in India. These facilities are strategically positioned in various cities and regions of India to ensure wide coverage and accessibility for patients.

In addition to hospitals, Apollo also operates pharmacies and diagnostic centers, which are also located in India.

Revenue Growth: 18% (2024) Profit Growth: 14% (2024)

Apollo Hospitals Enterprise Limited is pursuing a multi-pronged growth strategy to further strengthen and expand its market position. A key component of this strategy is the expansion of the network through the establishment of new hospitals and medical facilities in underserved regions. This is intended not only to increase the company's reach but also to improve access to high-quality healthcare.

Another focus is on digitization and the implementation of modern technologies to enhance service efficiency and improve the patient experience. This includes the introduction of telemedicine services and the use of AI-based diagnostic tools.

In addition, Apollo Hospitals is investing in strategic partnerships and joint ventures to develop innovative healthcare solutions and tap into new markets. These initiatives aim to expand the service portfolio while increasing operational efficiency.

Imported Raw Materials/Supplies: Medical devices, Pharmaceutical products, Medical consumables

Main Import Countries: USA, Germany, China

Apollo Hospitals Enterprise Limited imports a variety of raw materials and supplies necessary for the operation of their hospitals and medical facilities. This includes medical devices such as MRI scanners and X-ray machines, which are often sourced from the USA and Germany as these countries are leading in medical technology.

Pharmaceutical products and medical consumables are also imported, with China being a significant supplier of cost-effective medical consumables. These imports are crucial to maintain the high quality of medical care and provide patients with access to the latest medical technologies and treatments.

Market share: 10% (estimated, 2025)
EBITDA margin: 18% (2024)
Net income growth: 14% (2024)

Apollo Hospitals Enterprise Limited has a significant competitive advantage in the Indian healthcare sector. With an estimated market share of 10% in 2025, the company is one of the leading providers of healthcare services in India.

The EBITDA margin of 18% in 2024 demonstrates the company's ability to operate efficiently and control costs, which is an important indicator of competitiveness. Additionally, the company shows solid net income growth of 14%, indicating strong demand for its services and successful expansion into new markets.

Apollo Hospitals benefits from its established brand, a wide network of hospitals, and specialized healthcare services. These factors help to solidify the company's competitive advantage and further strengthen its market position.

Institutional Investor Share: approximately 55% (2025, estimated) Insider Buys/Sells: No significant transactions in the last year (2025, estimated)

The institutional investor share in Apollo Hospitals Enterprise Limited is around 55%. This reflects the confidence of institutional investors in the company's long-term growth strategy and market position.

In 2025, there were no significant insider buys or sells, indicating a stable assessment of the company's value by management and other insiders. This could suggest that executives are satisfied with the current corporate strategy and do not anticipate any short-term changes.

Market share of Apollo Hospitals Enterprise Limited: 7% (estimated for 2025)

Top competitors and their market shares:

1. Fortis Healthcare Limited: 6%
2. Max Healthcare Institute Limited: 5%
3. Narayana Hrudayalaya Limited: 4%
4. Manipal Hospitals: 3%
5. Aster DM Healthcare: 3%
6. Medanta - The Medicity: 2%
7. KIMS Hospitals: 2%
8. Global Hospitals: 1.5%
9. Columbia Asia Hospitals: 1.5%
10. Care Hospitals: 1%

Apollo Hospitals Enterprise Limited is one of the leading providers in the Indian healthcare sector and has secured a significant market share through a wide range of services, strong brand recognition, and an extensive network of hospitals and clinics.

Apollo Hospitals' moat mainly consists of its established brand, comprehensive geographic presence, and the ability to offer specialized medical services. This gives the company a competitive advantage over smaller and less diversified providers.

Compared to its competitors, Apollo Hospitals has a stronger moat, particularly due to its innovation and investments in technology and infrastructure. However, Fortis Healthcare and Max Healthcare are also significant players with growing market presence and could compete in certain areas, such as specialized medical services.

Overall, Apollo Hospitals remains a leading player in the healthcare sector due to its strategic positioning and continuous investments in quality and technology.

Revenue Growth: 18% (2024) EBITDA Margin: 21% (2024) Market Share in Healthcare Sector India: 15% (2024)

Apollo Hospitals Enterprise Limited recorded strong revenue growth of 18% in 2024. This is attributed to the expansion of their services and increase in bed capacity. The EBITDA margin of 21% demonstrates solid operational efficiency, indicating effective cost controls and strong demand for their healthcare services.

The company holds a significant market share of 15% in the Indian healthcare sector, reflecting its leading position and patients' trust in its services. Furthermore, Apollo Hospitals continuously invests in digital health solutions and telemedicine, giving them a competitive advantage in an increasingly technology-oriented market.

Overall, the financial performance and strategic direction of the company suggest that Apollo Hospitals Enterprise Limited is a promising investment, especially for investors interested in long-term growth in the healthcare sector.

Dividend Yield: 0.5% (2024)
Dividend History: Regular payout over the last 5 years

Apollo Hospitals Enterprise Limited regularly pays dividends to its shareholders. The dividend yield was approximately 0.5% in 2024. This indicates that the company pays dividends, but with a relatively low yield compared to other companies in the healthcare sector.

The reliability of Apollo Hospitals' dividend payments can be considered high, as the company has consistently distributed dividends over the past five years. This demonstrates a certain level of stability and commitment to shareholders, even though the yield is comparatively low.